Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2377
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study ; volume:16 ; number:1 ; day:21 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
BMC neurology ; 16, Heft 1 (21.9.2016), 1-9, 12.2016

Keyword
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Creator
Berge, Guro
Contributor
Sando, Sigrid B.
Albrektsen, Grethe
Lauridsen, Camilla
Møller, Ina
Grøntvedt, Gøril R.
Bråthen, Geir
White, Linda R.
SpringerLink (Online service)

DOI
10.1186/s12883-016-0706-0
URN
urn:nbn:de:1111-20170316974
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show object at data provider

Associated

  • Berge, Guro
  • Sando, Sigrid B.
  • Albrektsen, Grethe
  • Lauridsen, Camilla
  • Møller, Ina
  • Grøntvedt, Gøril R.
  • Bråthen, Geir
  • White, Linda R.
  • SpringerLink (Online service)

Other Objects (12)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein

α-synuclein in the pathophysiology of Alzheimer’s disease

α-synuclein in the pathophysiology of Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia

Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia

Alpha-Synuclein aggregate formation in oligodendroglia OLN-t40 cells stably transfected with alpha-Synuclein

Alpha-Synuclein aggregate formation in oligodendroglia OLN-t40 cells stably transfected with alpha-Synuclein

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Related objects